tranexamic acid has been researched along with Achromatopsia in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Achromatopsia: Severely deficient color perception, typically with monochromacy and reduced visual acuity. The atypical form can include normal visual acuity with pseudomonochromacy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cravens, GT | 1 |
| Brown, MJ | 1 |
| Brown, DR | 1 |
| Wass, CT | 1 |
1 other study available for tranexamic acid and Achromatopsia
| Article | Year |
|---|---|
Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: Postoperative visual color changes after tranexamic acid administration.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Chordoma; Color Perception; Color Vision Defects; Hum | 2006 |